This federal contract award is a Delivery Order (SPE2DB22D3016|SPE2DB25FAHV5) with a Firm Fixed Price type and a ceiling value of $1,510.90. The contract is for the delivery of M-M-R II vaccine vials and was awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor.
The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided about any subcontractors. The ultimate completion date for this specific Delivery Order is December 31, 2024.
Generated 3/31/25, 9:41 AM